Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Leerink Partners analyst Whit Mayo downgraded Elevance Health, Inc. ELV from Outperform to Market Perform and lowered the price target from $510 to $310. Elevance Health shares closed at $302.45 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Yi Chen downgraded the rating for Clearside Biomedical, Inc. CLSD from Buy to Neutral and maintained the price target of $5. Clearside Biomedical shares closed at $0.6018 on Thursday. See how other analysts view this stock.
- Evercore ISI Group analyst Samir Khanal downgraded Rexford Industrial Realty, Inc. REXR from Outperform to In-Line and lowered the price target from $39 to $38. Rexford Industrial Realty shares closed at $35.43 on Thursday. See how other analysts view this stock.
- Chardan Capital analyst Daniil Gataulin downgraded the rating for Clearside Biomedical, Inc. CLSD from Buy to Neutral. Clearside Biomedical shares closed at $0.6018 on Thursday. See how other analysts view this stock.
- Jefferies analyst David Stanton downgraded Mesoblast Limited MESO from Buy to Hold. Mesoblast shares closed at $12.34 on Thursday. See how other analysts view this stock.
Considering buying ELV stock? Here’s what analysts think:
Trending Investment Opportunities
Advertisement
Read This Next:
Photo via Shutterstock
Loading...
Loading...
CLSDClearside Biomedical Inc
$0.4182-30.5%
Edge Rankings
Momentum
9.23
Growth
N/A
Quality
N/A
Value
15.80
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
